SEC Form 4 · accession 0001225208-18-002889
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur C Butcher
Officer — SVP&Pres, Endoscopy
Period of report
Feb 12, 2018
Accepted (ET)
Feb 14, 2018 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Share UnitsF2,F1 | — | Feb 12, 2018 | A | 7,454 | A | Dec 31, 2019 | Dec 31, 2019 | Common Stock | 7,454 | 7,454 | D |
Explanation of responses
- F1Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2019.
Remarks
butcherpoa.txt